Abstract
Objectives Metabolic syndrome (MS) with its which is a clustering of atherogenic metabolic abnormalities is considered an important determinant of cardiovascular (CV) risk. Framingham risk scores (FRS) have been traditionally...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have